Interní Med. 2002; 4(5): 238-242

Hibernující myokard a jeho význam pro klinickou praxi

MUDr. Jana Gandalovičová
II. interní klinika kardiologie a angiologie 1. LF UK a VFN, Praha

Published: December 31, 2002  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Gandalovičová J. Hibernující myokard a jeho význam pro klinickou praxi. Interní Med. 2002;4(5):238-242.

Článek se zabývá termínem hibernující myokard, patofyziologií tohoto jevu, možnostmi detekce a jeho významem pro klinickou praxi. Vysvětluje význam a důležitost nálezu viabilního myokardu pro další terapeutický postup u pacientů s ischemickou kardiomyopatií s omezenou funkcí levé komory.

Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Alfridi I, et al. Dobutamine Echocardiography in Myocardial Hibernation: Optimal Dose and Accuracy in Predicting Recovery of Ventrical Function After Coronary Angioplasty. Circulation 1995; 91(3): 663-670. Go to original source... Go to PubMed...
    2. Allman KC, Shaw LJ, et al. Myocardial Viability Testing and Impact of Revascularization on Prognosis in Patients With Coronary Artery Disease and Left Ventricular Dysfunction: A Meta-Analysis. JACC 2002; 39: 1151-1158. Go to original source... Go to PubMed...
    3. Al-Mohammad A, Mahy IR, et al. Prevalence of hibernating myocardium in patients with severely impaired ischaemic left ventricles. Heart 1998; 80(6): 559-564. Go to original source... Go to PubMed...
    4. Al-Mohammad A, Norton MY, et al. Can the surface electrocardiogram be used to predict myocardial viability? Heart 1999; 82(6): 663-667. Go to original source... Go to PubMed...
    5. Auerbach MA, et al. Prevalence of myocardial viability as detected by positron emission tomography in patients with ischaemic cardiomyopathy. Circulation, 1999; 99: 2921-2926. Go to original source... Go to PubMed...
    6. Bax JJ, Poldermans D, et al. Improvement of left ventricular ejection fraction, heart failure symptoms and prognosis after revascularization in patients with chronic coronary aretery disease and viable myocardium detected by dobutamine stress echocardiography. JACC 1999; 34: 163-169. Go to original source... Go to PubMed...
    7. Bax JJ, Wijns W, et al. Accuracy of Currently Available Techniques for Prediction of Functional Recovery Asfter Revascularization in Patients With Left Ventricular Dysfunction Due to Chronic Coronary Aretry Disease: Comparison of Pooled Data. JACC 1997; 30: 1451-1460. Go to original source... Go to PubMed...
    8. Di Carli MF, et al. Quantitative relation between myocardial viability and improvement in heart failure symptoms after revascularization in patients with ischaemic cardiomyopathy. Circulation 1995; 92: 3436-3444. Go to original source... Go to PubMed...
    9. Eitzman D, et al. Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography. JACC 1992; 20: 559-565. Go to original source... Go to PubMed...
    10. Fallavollita JA, et al. Regional alterations in SR Ca 2+ATPase, phospholamban and HSP-70 expression in chronic hibernating myocardium. Am J Heart Circ Physiol 1999; 277: H1418-1428. Go to original source... Go to PubMed...
    11. Fath-Ordoubadi F, Beatt KJ, et al. Efficacy of coronary angioplasty for the treatment of hibernating myocardium. Heart 1999; 82: 210-216. Go to original source... Go to PubMed...
    12. Galiuto L and Iliceto S. Myocardial Contrast Echocardiography in the Evaluation of Viable Myocardium After Acute Myocardial Infarction. Am J Cardiol 1998; 81(12A): 29G-32G. Go to original source... Go to PubMed...
    13. Heusch G and Schultz RU. The biology of Myocardial Hibernation. Trends in Cardiovascular Medicine 2000; 10: 108-114. Go to original source... Go to PubMed...
    14. La Canna G, et al. Sensitivity, specificity, and predictive accuracies of noninvasive tests, singly and in combination, for diagnosis of hibernating myocardium. Eur Heart J 2000; 21: 1358-1367. Go to original source... Go to PubMed...
    15. Mesotten L, et al. PET radiopharmaceuticals used in viability studies in acute myocardial infarction: a literature survey. Eur J Nucl Med 2002; 29: 3-6. Go to original source... Go to PubMed...
    16. Pagano D, et al. Effects of coronary revascularization on myocardial blood flow and coronary vasodilator reserve in hibernating myocardium. Heart 2001; 85: 208-212. Go to original source... Go to PubMed...
    17. Pagano D, Townend JN, Bonser Rs. What is the role of revascularization in ischaemic heart failure. Heart 1999 81: 8-9. Go to original source... Go to PubMed...
    18. Shah BR, et al. Revascularization improves survival in ischemic cardiomyopathy regardless of electrocardiographic criteria for prior small-to-medium myocardial infarcts. Am Heart J 2002; 143: 111-117. Go to original source... Go to PubMed...
    19. Wijns W, Vatner SF and Camici PG. Hibernating Myocardium. N Engl J Med 1998; 339: 173-181. Go to original source... Go to PubMed...

    Return to the content


    Internal Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.